AP1976A - Disulfide, sulfide, sulfoxide and sulfone derivatives of cyclic sugars and uses thereof - Google Patents

Disulfide, sulfide, sulfoxide and sulfone derivatives of cyclic sugars and uses thereof

Info

Publication number: AP1976A
Authority: AP; ARIPO
Prior art keywords: disulfide; sulfoxide; sulfide; sulfone derivatives; cyclic sugars
Prior art date: 2003-10-03

Application number

AP2006003605A

Other languages

English (en)

Other versions

AP2006003605A0 (en

Inventor

Moliner Jose Repolles

Perez-Rasilla Eduardo Salas

Coy Francisco Pubill

Original Assignee

Lacer Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-10-03

Filing date

2004-09-29

Publication date

2009-03-16

2004-09-29 Application filed by Lacer Sa filed Critical Lacer Sa

2006-04-30 Publication of AP2006003605A0 publication Critical patent/AP2006003605A0/xx

2009-03-16 Application granted granted Critical

2009-03-16 Publication of AP1976A publication Critical patent/AP1976A/xx

Links

BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 title 1
UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 title 1
235000000346 sugar Nutrition 0.000 title 1
-1 sulfone derivatives of cyclic sugars Chemical class 0.000 title 1
150000003462 sulfoxides Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Biomedical Technology (AREA)
Endocrinology (AREA)
Obesity (AREA)
Hospice & Palliative Care (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Emergency Medicine (AREA)
Biochemistry (AREA)
Urology & Nephrology (AREA)
Psychiatry (AREA)
Immunology (AREA)
Toxicology (AREA)
Gynecology & Obstetrics (AREA)
Reproductive Health (AREA)
Dermatology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AP2006003605A 2003-10-03 2004-09-29 Disulfide, sulfide, sulfoxide and sulfone derivatives of cyclic sugars and uses thereof AP1976A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
ES200302368A ES2258365B1 (es)	2003-10-03	2003-10-03	Derivados de disulfuro, sulfuro, sulfoxido y sulfona de azucares ciclicos y sus usos.
PCT/EP2004/010882 WO2005037842A1 (en)	2003-10-03	2004-09-29	Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses thereof

Publications (2)

Publication Number	Publication Date
AP2006003605A0 AP2006003605A0 (en)	2006-04-30
AP1976A true AP1976A (en)	2009-03-16

Family

ID=34451643

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AP2006003605A AP1976A (en)	2003-10-03	2004-09-29	Disulfide, sulfide, sulfoxide and sulfone derivatives of cyclic sugars and uses thereof

Country Status (34)

Country	Link
US (3)	US7521571B2 (is)
EP (1)	EP1668017B1 (is)
JP (2)	JP4809769B2 (is)
KR (1)	KR101141683B1 (is)
CN (1)	CN1863805B (is)
AP (1)	AP1976A (is)
AR (1)	AR045962A1 (is)
AT (1)	ATE423781T1 (is)
AU (1)	AU2004281916B2 (is)
BR (1)	BRPI0415020A (is)
CA (1)	CA2540500C (is)
DE (2)	DE602004019666D1 (is)
DK (1)	DK1668017T3 (is)
EA (1)	EA008942B1 (is)
EC (1)	ECSP066542A (is)
ES (2)	ES2258365B1 (is)
GB (1)	GB2421241B (is)
GE (1)	GEP20084490B (is)
GT (1)	GT200400200A (is)
HR (1)	HRP20090152T3 (is)
IL (1)	IL174371A0 (is)
IS (1)	IS8436A (is)
MX (1)	MXPA06003610A (is)
NO (1)	NO20061872L (is)
NZ (1)	NZ546043A (is)
PA (1)	PA8614201A1 (is)
PE (1)	PE20050436A1 (is)
PL (1)	PL1668017T3 (is)
PT (1)	PT1668017E (is)
RS (1)	RS20060241A (is)
SI (1)	SI1668017T1 (is)
UY (1)	UY28547A1 (is)
WO (1)	WO2005037842A1 (is)
ZA (1)	ZA200603475B (is)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2258365B1 (es) *	2003-10-03	2007-12-01	Lacer, S.A.	Derivados de disulfuro, sulfuro, sulfoxido y sulfona de azucares ciclicos y sus usos.
EP1941876A1 (en) *	2006-12-28	2008-07-09	Lacer, S.A.	Isosorbide mononitrate derivatives for the treatment of Inflammation and ocular hypertension
ES2332565B1 (es) *	2007-01-23	2010-10-21	Lacer, S.A.	Uso de derivados de mononitrato de dianhidrohexita como agentes antiinflamatorios.
JP2010518171A (ja) *	2007-02-13	2010-05-27	ギリアード・パロ・アルト・インコーポレイテッド	非冠微小血管疾患の処置のためのラノラジンの使用
US20080248112A1 (en) *	2007-02-13	2008-10-09	Brent Blackburn	Use of ranolazine for the treatment of coronary microvascular diseases
US20090111826A1 (en) *	2007-02-13	2009-04-30	Louis Lange	Use of ranolazine for the treatment of cardiovascular diseases
EP2117508A1 (en) *	2007-02-13	2009-11-18	CV Therapeutics Inc.	Intravenous solutions comprising ranolazine
US20080233191A1 (en) *	2007-03-22	2008-09-25	Brent Blackburn	Use of ranolazine for elevated brain-type natriuretic peptide
WO2008150565A2 (en) *	2007-05-31	2008-12-11	Cv Therapeutics, Inc.	Ranolazine for elevated brain-type natriuretic peptide
IE20070934A1 (en)	2007-12-21	2009-06-24	Trinity College Dublin	Efficient aspirin prodrugs
WO2009098113A1 (en) *	2008-02-07	2009-08-13	Nicox S.A.	Nitric oxide donor compounds
EP2149576A1 (en)	2008-07-22	2010-02-03	Lacer, S.A.	Isosorbide Nitrates having vasodilating activity
EP2149577B1 (en) *	2008-07-22	2011-04-27	Lacer, S.A.	New stereospecific method for the preparation of dioxa-bicyclooctane compounds
EP2177216A1 (en) *	2008-10-13	2010-04-21	Lacer, S.A.	Use of dianhydrohexite mononitrate derivatives as healing agents
WO2010055138A1 (en) *	2008-11-14	2010-05-20	Lacer, S.A.	New stereospecific method for the preparation of dioxa-bicyclooctane compounds
EP2199294A1 (en)	2008-12-19	2010-06-23	Lacer, S.A.	New stereospecific method for the preparation of dioxa bicyclooctane nitrate compounds
US20130131161A1 (en) *	2009-12-23	2013-05-23	Michael R. Bristow	Methods and compositions for cardiovascular diseases and conditions
FR2977252B1 (fr) *	2011-06-30	2013-08-02	Seppic Sa	Nouveaux esters de derives n-acyles d'acides amines et d'isosorbide, procede pour leur preparation, et utilisation en cosmetique et comme medicament.
JP6021938B2 (ja)	2011-12-16	2016-11-09	スリーエムイノベイティブプロパティズカンパニー	メルカプト含有ビスアンヒドロヘキシトール誘導体及びその使用
CA2902009A1 (en) *	2013-03-05	2014-09-12	Archer Daniels Midland Company	Isohexide monotriflates and process for synthesis thereof
CN116173012A (zh) *	2022-12-05	2023-05-30	温州医科大学	白当归脑在制备缺血性脑卒中神经保护用药物中的应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0290885A2 (en) *	1987-05-08	1988-11-17	CHIESI FARMACEUTICI S.p.A.	1,4:3,6-Dianhydrosorbitol 2-mono-nitrate and 5-mononitrate esters, a process for the preparation thereof and pharmaceutical compositions therefrom
EP0530887A1 (fr) *	1991-08-07	1993-03-10	Laboratoires Hoechst S.A.	Nitrates organiques, leurs procédés de préparation et leur utilisation dans le traitement de maladies cardiovasculaires
WO2000020420A1 (es) *	1998-10-07	2000-04-13	Lacer, S.A.	Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia disminuida

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3886186A (en)	1971-04-29	1975-05-27	American Home Prod	Mononitrate esters of 1,4:3,6-dianhydro-d-glucitol
GB1356374A (en) *	1971-04-29	1974-06-12	American Home Prod	Mononitrate esters of 1,3 3,6-dianhydro-d-glucitol
DE3102947A1 (de)	1981-01-29	1982-09-02	Heinrich Mack Nachf., 7918 Illertissen	Verfahren zur herstellung von isosorbid-5-nitrat
US4891373A (en) *	1988-11-23	1990-01-02	Pfizer Inc.	Aminopropanol derivatives of 1,4:3,6-dianhydrohexitol nitrates, processes for their preparation and their use as medicaments
ES2125342T3 (es) *	1992-07-30	1999-03-01	Cal Int Ltd	Esteres y combinaciones de un nitrato organico y de un salicilato.
DE4410997A1 (de) *	1994-03-30	1995-10-26	Isis Pharma Gmbh	Pharmazeutische Zubereitungen und Arzneistoffe zur Prävention und Behandlung endothelialer Dysfunktionen
IL120531A (en) *	1997-03-26	2006-12-31	Yissum Res Dev Co	Nitric oxide donors and pharmaceutical compositions containing them
US20020013483A1 (en) *	2000-07-13	2002-01-31	Consortium Fur Elektrochemische Industrie Gmbh	Process for the preparation of dianhydrohexitol bisacylates
JP2004521083A (ja) *	2000-10-27	2004-07-15	ニトロメッド，インク．	酸化窒素不足によって特徴づけられる血管疾患の治療方法
UA63467A (en)	2003-04-22	2004-01-15		Pharmaceutical composition of organic nitrates, dosage form based on pharmaceutical composition of organic nitrates and method of manufacture
ES2258365B1 (es) *	2003-10-03	2007-12-01	Lacer, S.A.	Derivados de disulfuro, sulfuro, sulfoxido y sulfona de azucares ciclicos y sus usos.

2003
- 2003-10-03 ES ES200302368A patent/ES2258365B1/es not_active Expired - Fee Related
2004
- 2004-09-29 CA CA2540500A patent/CA2540500C/en not_active Expired - Fee Related
- 2004-09-29 SI SI200431109T patent/SI1668017T1/sl unknown
- 2004-09-29 AP AP2006003605A patent/AP1976A/xx active
- 2004-09-29 EA EA200600694A patent/EA008942B1/ru not_active IP Right Cessation
- 2004-09-29 WO PCT/EP2004/010882 patent/WO2005037842A1/en not_active Ceased
- 2004-09-29 RS YUP-2006/0241A patent/RS20060241A/sr unknown
- 2004-09-29 EP EP04765682A patent/EP1668017B1/en not_active Expired - Lifetime
- 2004-09-29 GE GEAP20049372A patent/GEP20084490B/en unknown
- 2004-09-29 DE DE602004019666T patent/DE602004019666D1/de not_active Expired - Lifetime
- 2004-09-29 PL PL04765682T patent/PL1668017T3/pl unknown
- 2004-09-29 DE DE112004001860T patent/DE112004001860T5/de not_active Withdrawn
- 2004-09-29 DK DK04765682T patent/DK1668017T3/da active
- 2004-09-29 JP JP2006530042A patent/JP4809769B2/ja not_active Expired - Fee Related
- 2004-09-29 PT PT04765682T patent/PT1668017E/pt unknown
- 2004-09-29 KR KR1020067006283A patent/KR101141683B1/ko not_active Expired - Fee Related
- 2004-09-29 HR HR20090152T patent/HRP20090152T3/xx unknown
- 2004-09-29 CN CN2004800289355A patent/CN1863805B/zh not_active Expired - Fee Related
- 2004-09-29 ES ES04765682T patent/ES2322468T3/es not_active Expired - Lifetime
- 2004-09-29 GB GB0605574A patent/GB2421241B/en not_active Expired - Fee Related
- 2004-09-29 AU AU2004281916A patent/AU2004281916B2/en not_active Ceased
- 2004-09-29 AT AT04765682T patent/ATE423781T1/de not_active IP Right Cessation
- 2004-09-29 NZ NZ546043A patent/NZ546043A/en unknown
- 2004-09-29 BR BRPI0415020-1A patent/BRPI0415020A/pt not_active IP Right Cessation
- 2004-09-29 MX MXPA06003610A patent/MXPA06003610A/es active IP Right Grant
- 2004-09-29 US US10/544,237 patent/US7521571B2/en not_active Expired - Fee Related
- 2004-09-30 PE PE2004000957A patent/PE20050436A1/es not_active Application Discontinuation
- 2004-10-01 AR ARP040103576A patent/AR045962A1/es unknown
- 2004-10-01 UY UY28547A patent/UY28547A1/es not_active Application Discontinuation
- 2004-10-01 GT GT200400200A patent/GT200400200A/es unknown
- 2004-10-01 PA PA20048614201A patent/PA8614201A1/es unknown
2006
- 2006-03-16 IL IL174371A patent/IL174371A0/en unknown
- 2006-04-27 NO NO20061872A patent/NO20061872L/no not_active Application Discontinuation
- 2006-05-02 ZA ZA200603475A patent/ZA200603475B/xx unknown
- 2006-05-03 EC EC2006006542A patent/ECSP066542A/es unknown
- 2006-05-03 IS IS8436A patent/IS8436A/is unknown
2009
- 2009-03-09 US US12/400,394 patent/US7777058B2/en not_active Expired - Fee Related
2010
- 2010-04-06 US US12/755,103 patent/US8541607B2/en not_active Expired - Fee Related
- 2010-10-08 JP JP2010228789A patent/JP2011012081A/ja active Pending

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0290885A2 (en) *	1987-05-08	1988-11-17	CHIESI FARMACEUTICI S.p.A.	1,4:3,6-Dianhydrosorbitol 2-mono-nitrate and 5-mononitrate esters, a process for the preparation thereof and pharmaceutical compositions therefrom
EP0530887A1 (fr) *	1991-08-07	1993-03-10	Laboratoires Hoechst S.A.	Nitrates organiques, leurs procédés de préparation et leur utilisation dans le traitement de maladies cardiovasculaires
WO2000020420A1 (es) *	1998-10-07	2000-04-13	Lacer, S.A.	Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia disminuida

Also Published As

Publication number	Publication date
DK1668017T3 (da)	2009-05-11
ES2322468T3 (es)	2009-06-22
GB2421241A (en)	2006-06-21
HRP20090152T3 (en)	2009-05-31
UY28547A1 (es)	2005-04-29
GB0605574D0 (en)	2006-04-26
PL1668017T3 (pl)	2009-07-31
SI1668017T1 (sl)	2009-08-31
EP1668017A1 (en)	2006-06-14
AU2004281916A1 (en)	2005-04-28
AP2006003605A0 (en)	2006-04-30
PE20050436A1 (es)	2005-06-23
WO2005037842A1 (en)	2005-04-28
ES2258365B1 (es)	2007-12-01
CN1863805A (zh)	2006-11-15
US8541607B2 (en)	2013-09-24
CA2540500C (en)	2012-08-28
IL174371A0 (en)	2006-08-01
KR101141683B1 (ko)	2012-05-07
JP4809769B2 (ja)	2011-11-09
PA8614201A1 (es)	2005-05-24
MXPA06003610A (es)	2006-06-05
EA200600694A1 (ru)	2006-10-27
RS20060241A (sr)	2008-06-05
ECSP066542A (es)	2006-10-17
JP2007507451A (ja)	2007-03-29
CN1863805B (zh)	2010-06-16
KR20060066743A (ko)	2006-06-16
US7521571B2 (en)	2009-04-21
DE112004001860T5 (de)	2006-07-27
JP2011012081A (ja)	2011-01-20
EA008942B1 (ru)	2007-10-26
AR045962A1 (es)	2005-11-16
ZA200603475B (en)	2007-09-26
HK1092807A1 (en)	2007-02-16
NZ546043A (en)	2009-02-28
DE602004019666D1 (de)	2009-04-09
US20090169560A1 (en)	2009-07-02
ATE423781T1 (de)	2009-03-15
GEP20084490B (en)	2008-09-25
GT200400200A (es)	2005-05-23
US20060235052A1 (en)	2006-10-19
CA2540500A1 (en)	2005-04-28
BRPI0415020A (pt)	2006-11-07
GB2421241B (en)	2008-04-16
EP1668017B1 (en)	2009-02-25
ES2258365A1 (es)	2006-08-16
NO20061872L (no)	2006-06-30
AU2004281916B2 (en)	2010-10-21
US20100196387A1 (en)	2010-08-05
PT1668017E (pt)	2009-03-09
US7777058B2 (en)	2010-08-17
IS8436A (is)	2006-05-03

Publication	Publication Date	Title
AP1976A (en)	2009-03-16	Disulfide, sulfide, sulfoxide and sulfone derivatives of cyclic sugars and uses thereof
DK1919458T3 (da)	2012-08-20	Syreresistent cysteamin, cystamin og derivater deraf
DK1604915T4 (da)	2020-01-02	Lukket kapsel med åbningsorgan
ATE556593T1 (de)	2012-05-15	Herbizide enthaltend substituierte thien-3-yl- sulfonylamino(thio)carbonyltriazolin(thi)one und flurtamone
HUS1600006I1 (hu)	2016-02-29	Helyettesített tien-3-il-szulfonilamino(tio)karboniltriazolin(ti)on-on és 4-HPPD inhibitorokon alapuló gyomirtó készítmények
EP1953194A4 (en)	2009-09-16	Polyarylene sulfide compound
ATE407172T1 (de)	2008-09-15	Schwefelpellet mit h2s-unterdrückungsmittel
AU2003228068A1 (en)	2003-12-22	Content augmentation based on personal profiles
ATE354566T1 (de)	2007-03-15	Aromatische sulfone und deren medizinische verwendung
NO20053564D0 (no)	2005-07-20	Bis(3)-alkoksyalkan-2-ol)sulfider, sulfoner og sulfoksider: nye overflateaktive midler.
FI20020614A0 (fi)	2002-03-28	Henkilökohtainen viestinlaite, jossa on kaksi osaa ja korostuneet mahdollisuudet itseilmaisuun
IL168893A (en)	2010-11-30	Sulfide-containing polythiols
PL376646A1 (pl)	2006-01-09	Prefabrykowany element budowlany
IL179419A0 (en)	2007-05-15	Heteroaryl sulfones and sulfonamides and therapeutic uses thereof
ATE412645T1 (de)	2008-11-15	Substituierte thiophene und deren verwendungen
ITBO20050394A1 (it)	2005-09-07	Pacchetto per il contenimento di articoli sfusi sbozzato per la realizzazione di tale pacchetto e metodo di piegatura di tale sbozzato
DK1896401T3 (da)	2013-06-17	Syntese af umættede sulfider, sulfoner, sulfoxider og sulfonamider
AU2003235697A1 (en)	2003-07-30	Phenyl sulfoxides and phenyl sulfones
ITMI20020772A0 (it)	2002-04-10	Meccanismo per ante scorrevoli
AU2003295243A8 (en)	2004-07-29	Electronic dictionary with illustrative sentences
AP2022A (en)	2009-08-10	Pesticidal treatment of stored foodstuffs, chambers, structures and works of art with sulphur compounds
AU2003215665A1 (en)	2003-10-08	Probucol derivatives
AU2003293573A1 (en)	2004-07-22	Bow limb fixation member
GB0228870D0 (en)	2003-01-15	Sulphur dioxide release coastings
TW517772U (en)	2003-01-11	Integral structure of auto-door with capable of overall open function